Alyssa Piljan-Gentle

Baughman RP

Ganser GL

Hardie WD

Liu J

Machiko Ikegami

Michelle R. Dunlavy

Thomas R. Korfhagen

Van Winkle LS

William D. Hardie

 Transgenic mice overexpressing human transforming growth factor-α (TGF-α) develop emphysema and fibrosis during postnatal alveologenesis. To assess dose-related pulmonary alterations, four distinct transgenic lines expressing different amounts of TGF-α in the distal lung under control of the surfactant protein C (SP-C) promoter were characterized. Mean lung homogenate TGF-α levels ranged from 388 ± 40 pg/ml in the lowest expressing line to 1,247 ± 33 pg/ml in the highest expressing line. Histological assessment demonstrated progressive alveolar airspace size changes that were more severe in the higher expressing TGF-α lines. Pleural and parenchymal fibrosis were only detected in the highest expressing line ( line 28), and increasing terminal airspace area was associated with increasing TGF-α expression. Hysteresis on pressure-volume curves was significantly reduced in line 28 mice compared with other lines of mice. There were no differences in bronchoalveolar lavage fluid cell count or differential that would indicate any evidence of lung inflammation among all transgenic lines. Proliferating cells were increased in line 28 without alterations of numbers of type II cells. We conclude that TGF-α lung remodeling in transgenic mice is dose dependent and is independent of pulmonary inflammation. </jats:p

Crossref

AJP Lung Cellular and Molecular Physiology

Dose-dependent lung remodeling in transgenic mice  expressing transforming growth factor-α

Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-α

Abstract

Similar works

Full text

Available Versions

Crossref